v3.26.1
Equity - Additional Information (Details)
1 Months Ended 3 Months Ended 6 Months Ended
Jun. 30, 2026
USD ($)
Vote
$ / shares
shares
Feb. 27, 2026
USD ($)
$ / shares
Jun. 30, 2026
USD ($)
Vote
$ / shares
shares
Jun. 30, 2026
USD ($)
Vote
$ / shares
shares
Jun. 30, 2026
USD ($)
Vote
$ / shares
shares
Dec. 31, 2025
$ / shares
shares
Nov. 11, 2025
USD ($)
Jun. 30, 2025
$ / shares
Mar. 18, 2025
$ / shares
Schedule of Capitalization, Equity [Line Items]                  
Common stock, issued 23,650,757   23,650,757 23,650,757 23,650,757 22,111,165      
Common stock shares, authorized 450,000,000   450,000,000 450,000,000 450,000,000 450,000,000      
Common stock, par value | $ / shares $ 0.01 $ 0.01 $ 0.01 $ 0.01 $ 0.01 $ 0.01      
Gross proceeds from sale of shares | $         $ 17,164,000        
Common stock, voting rights         The shares of the Company’s common stock entitle the holders to one vote per share on all matters upon which stockholders are entitled to vote, to receive dividends and other distributions as authorized by the Board of Directors in accordance with the Maryland General Corporation Law, and to all rights of the stockholder pursuant to the Maryland General Corporation Law.        
Number of vote per share | Vote 1   1 1 1        
Share Repurchase Program, Authorized, Amount | $             $ 75,000,000    
Quarterly distribution per share | $ / shares $ 0.43   $ 0.43 $ 0.43 $ 0.43     $ 0.43  
Dividends                  
Schedule of Capitalization, Equity [Line Items]                  
Quarterly distribution per share | $ / shares $ 0.215   $ 0.215 $ 0.215 $ 0.215        
O2025 Q1 Dividends                  
Schedule of Capitalization, Equity [Line Items]                  
Quarterly distribution per share | $ / shares                 $ 0.215
Preferred Stock                  
Schedule of Capitalization, Equity [Line Items]                  
Preferred stock, shares authorized 50,000,000   50,000,000 50,000,000 50,000,000        
Preferred stock, par value | $ / shares $ 0.01   $ 0.01 $ 0.01 $ 0.01        
At-the Market Equity Program                  
Schedule of Capitalization, Equity [Line Items]                  
Sale of borrowed shares | $ / shares $ 19.5   $ 19.5 $ 19.5 19.5        
Shares sold     2,588,775            
Gross proceeds from sale of shares | $     $ 50,500,000            
Number of shares settled       898,983          
Proceeds from issuance of shares settled | $       $ 17,300,000          
Number of shares left to be settled 1,689,792                
Proceeds from issuance of shares left to be settled | $ $ 32,200,000                
Forward Sale Agreements                  
Schedule of Capitalization, Equity [Line Items]                  
Sale of borrowed shares | $ / shares $ 19.5   $ 19.5 $ 19.5 $ 19.5        
Common stock shares, authorized 1,819,387   1,819,387 1,819,387 1,819,387        
Shares sold     1,819,387            
Weighted average price per share | $ / shares         $ 19.266        
Forward price reduction description         The forward price is subject to reduction on each Forward Price Reduction Date (June 30, September 30, and December 31, 2026, and March 31, 2027) by $0.215 per share, representing the per-share quarterly dividend declared on the Company’s common stock.        
Adjusted forward price amount per share | $ / shares $ 19.08   $ 19.08 $ 19.08 $ 19.08        
Proceeds from sale of stock upon settlement | $         $ 2,500,000        
Shares unsettled         1,689,792        
Shares settled         129,595        
Proceeds from forward sale agreements settlement amount | $ $ 32,200,000   $ 32,200,000 $ 32,200,000 $ 32,200,000        
Maximum                  
Schedule of Capitalization, Equity [Line Items]                  
Aggregate gross sales price | $   $ 75,000,000